Article Details

Quantum BioPharma Advances Multiple Sclerosis Drug Toward Clinical Trials with Final ...

Retrieved on: 2025-10-02 22:30:34

Tags for this article:

Click the tags to see associated articles and topics

Quantum BioPharma Advances Multiple Sclerosis Drug Toward Clinical Trials with Final .... View article details on hiswai:

Excerpt

Quantum BioPharma Ltd. has received final reports from its 90-day oral toxicity and toxicokinetic studies for Lucid-MS, moving the potential ...

Article found on: www.citybuzz.co

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo